Therapeutic approach based on GDF5 to counteract age-related muscle wasting - Sorbonne Université
Poster De Conférence Année : 2022

Therapeutic approach based on GDF5 to counteract age-related muscle wasting

Massiré Traoré
  • Fonction : Auteur
Chiara Noviello
  • Fonction : Auteur
Gentil Christel
  • Fonction : Auteur
Julien Messéant
  • Fonction : Auteur
Ericky Caldas
  • Fonction : Auteur
Bruno Cadot
  • Fonction : Auteur
Laure Strochlich
  • Fonction : Auteur
Benjamin Marty
  • Fonction : Auteur
France Piétri-Rouxel
  • Fonction : Auteur

Résumé

One of the major concern of the public health system is represented by the growing number of people suffering of sarcopenia, a disease characterized by a progressive loss of skeletal muscle force, quality and mass during aging which results in increased debility and death. Despite several studies carried out on the various aspects of this disease, no cure has been established, so far. In our previous work, we showed that GDF5 overexpression prevents age-related muscle wasting, however, a deeper report on mechanisms and consequences of GDF5 implement on aged muscle was missing. We now present an extensive characterization of the physiological and molecular effects of GDF5 in muscle during aging and show its “rejuvenating signature”. Based on this proof of concept, we defined a cutting-edge therapeutic approach describing how the recombinant GDF5 treatment is able to fight the age-related skeletal muscle wasting in mice and represents a strong curative potential on humans.
Fichier principal
Vignette du fichier
Falcone EMBO 2022.pdf (1.34 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04002159 , version 1 (02-03-2023)

Identifiants

  • HAL Id : hal-04002159 , version 1

Citer

Massiré Traoré, Chiara Noviello, Gentil Christel, Julien Messéant, Ericky Caldas, et al.. Therapeutic approach based on GDF5 to counteract age-related muscle wasting. Muscle formation, maintenance, regeneration and pathology-EMBO workshop, Apr 2022, Gouvieux (FR), France. ⟨hal-04002159⟩
160 Consultations
63 Téléchargements

Partager

More